Progress in Diagnosis and Treatment of Primary Biliary Cholangitis
10.3969/j.issn.1008-7125.2018.05.003
- VernacularTitle:原发性胆汁性胆管炎的诊治进展
- Author:
Yiwen SHI
1
;
Hong YOU
Author Information
1. 首都医科大学附属北京友谊医院肝病研究中心 肝硬化转化医学北京市重点实验室 国家消化系统疾病临床医学研究中心 100050
- Keywords:
Primary Biliary Cholangitis;
Ursodeoxycholic Acid;
Diagnosis;
Therapy
- From:
Chinese Journal of Gastroenterology
2018;23(5):266-270
- CountryChina
- Language:Chinese
-
Abstract:
In the past 40 years,patients with primary biliary cholangitis (PBC)have benefited from the extensive use of ursodeoxycholic acid (UDCA),resulting in increase of response rate and survival rate. The prognosis of PBC patients was significantly improved. However,some patients responded poorly to UDCA and with poor long-term outcome. Therefore,accurate diagnosis,evaluation and risk stratification based on serological and pathological characteristics of the patients are very important for the treatment of PBC. This article summarized the progress in diagnosis and treatment of PBC.
